Ticker archive · $SPTX

$SPTX Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $SPTX — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$SPTX

$SPTX – Seaport Therapeutics Reports Q3 Net Loss of $26.4M, Cash at $403.8M

Seaport Therapeutics, Inc.

2026-11-02 00:00:00 UTC · SEC_8K · All $SPTX

?? Negative AI Sentiment (-1.5 / 10)

Q3 2026 net loss expanded to $26.4 million from $22.5 million year-over-year.
Cash, cash equivalents, and investments stood at $403.8 million as of September 30, 2026.
Phase 2/3 initiation for GlyphAgo planned for first half of 2027.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?